NCT00169520View on ClinicalTrials.gov

SB-715992 In Combination With Docetaxel In Patients With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2004

Conditions
Solid Tumor Cancer
Interventions
DRUG

docetaxel

DRUG

SB-715992

Trial Locations (2)

OX2 6PD

GSK Investigational Site, Oxford

SW3 6JJ

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY